Mirko Wäckerle
Director/Miembro de la Junta en Zweite DEWB Vermögensverwaltungs AG .
Cargos activos de Mirko Wäckerle
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Zweite DEWB Vermögensverwaltungs AG | Director/Miembro de la Junta | 03/06/2010 | - |
JENOPTIK siebente Vermögens AG | Director/Miembro de la Junta | 03/06/2010 | - |
SMARTRAC TECHNOLOGY Dresden GmbH
SMARTRAC TECHNOLOGY Dresden GmbH Electronic Production EquipmentElectronic Technology SMARTRAC TECHNOLOGY Dresden GmbH engages in the design, manufacture, and testing of electronic and electromechanical components, particularly miniaturized components. It specializes in technologies for the production of electronic circuit boards, installation of microassemblies, as well as the development and manufacture of equipment for the production and testing of microasseblies. The company was founded in November 1994 and is headquartered in Dresden, Germany. | Corporate Officer/Principal | - | - |
Director/Miembro de la Junta | - | - | |
Director Financiero/CFO | - | - |
Historial de carrera de Mirko Wäckerle
Antiguos cargos conocidos de Mirko Wäckerle.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
DEWB AG (Venture Capital)
DEWB AG (Venture Capital) Investment ManagersFinance DEWB AG (Venture Capital) (DEWB-VC) is the venture capital subsidiary of Deutsche Effecten & Wechsel Beteiligungs AG (FR: EFF), headquartered in Jena, Germany. The firm, established in 1997, provides equity capital, corporate development expertise and network support to strong growth, medium-sized technology companies. | Director Financiero/CFO | 01/01/2000 | 31/12/2011 |
Miembro del Comité de Inversión | 01/01/2000 | 31/12/2011 | |
DEUTSCHE EFFECTEN- UND WECHSEL-BETEILIGUNGSGESELLSCHAFT AG | Corporate Officer/Principal | 03/06/2010 | - |
Integrated Genomics, Inc.
Integrated Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Founded in 1997, Chicago-based Integrated Genomics™ specializes in research in microbial genomics, biochemistry, and gene expression. Its scientists has broad experience in both in silico and wet lab sequencing, research and development with more than 100 relevant publications in these areas. Integrated Genomics™ has particularly long-standing relationships and active research in the area of lactic acid bacteria and pathogenic microbes, as well as a broad customer base across industry, academic and government institutions. Integrated Genomics™' products and services are based on ERGO™, its web-based genome analysis platform. ERGO™ integrates proprietary functional genomic data, metabolic reconstructions, expression profiling, and biochemical and microbiological data with publicly available information. Focused on microbial genomics, ERGO™ provides better and faster identification of gene function across all organisms. In 2010 Integrated Genomics, Inc.'s business operations were transitioned to a new corporation, IG Assets, Inc. With the original Integrated Genomics' team, IG Assets continues to provide the same ERGO-based microbial genomic products and service. | Director/Miembro de la Junta | 03/06/2010 | 10/06/2011 |
Estadísticas
Internacional
Alemania | 6 |
Estados Unidos | 2 |
Operativa
Director/Board Member | 4 |
Director of Finance/CFO | 2 |
Corporate Officer/Principal | 2 |
Sectorial
Finance | 3 |
Commercial Services | 2 |
Electronic Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
DEUTSCHE EFFECTEN- UND WECHSEL-BETEILIGUNGSGESELLSCHAFT AG | Finance |
Empresas privadas | 5 |
---|---|
Integrated Genomics, Inc.
Integrated Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Founded in 1997, Chicago-based Integrated Genomics™ specializes in research in microbial genomics, biochemistry, and gene expression. Its scientists has broad experience in both in silico and wet lab sequencing, research and development with more than 100 relevant publications in these areas. Integrated Genomics™ has particularly long-standing relationships and active research in the area of lactic acid bacteria and pathogenic microbes, as well as a broad customer base across industry, academic and government institutions. Integrated Genomics™' products and services are based on ERGO™, its web-based genome analysis platform. ERGO™ integrates proprietary functional genomic data, metabolic reconstructions, expression profiling, and biochemical and microbiological data with publicly available information. Focused on microbial genomics, ERGO™ provides better and faster identification of gene function across all organisms. In 2010 Integrated Genomics, Inc.'s business operations were transitioned to a new corporation, IG Assets, Inc. With the original Integrated Genomics' team, IG Assets continues to provide the same ERGO-based microbial genomic products and service. | Commercial Services |
SMARTRAC TECHNOLOGY Dresden GmbH
SMARTRAC TECHNOLOGY Dresden GmbH Electronic Production EquipmentElectronic Technology SMARTRAC TECHNOLOGY Dresden GmbH engages in the design, manufacture, and testing of electronic and electromechanical components, particularly miniaturized components. It specializes in technologies for the production of electronic circuit boards, installation of microassemblies, as well as the development and manufacture of equipment for the production and testing of microasseblies. The company was founded in November 1994 and is headquartered in Dresden, Germany. | Electronic Technology |
DEWB AG (Venture Capital)
DEWB AG (Venture Capital) Investment ManagersFinance DEWB AG (Venture Capital) (DEWB-VC) is the venture capital subsidiary of Deutsche Effecten & Wechsel Beteiligungs AG (FR: EFF), headquartered in Jena, Germany. The firm, established in 1997, provides equity capital, corporate development expertise and network support to strong growth, medium-sized technology companies. | Finance |
Zweite DEWB Vermögensverwaltungs AG | |
JENOPTIK siebente Vermögens AG |
- Bolsa de valores
- Insiders
- Mirko Wäckerle
- Experiencia